Level: All
When we, the JMP development team, develop analytical capabilities, we must decide which of the following we prioritize:
- Building muscle makes JMP stronger
- Making JMP sexier
- JMP eases user pain points (reduces user frustration and burden)
Some of the longer English words that start with "A" are anabolic (a muscle-building agent), aphrodisiac (aphrodisiac), and analgesic (painkiller). Which of these three should we aim for? The speaker believes we should aim for "analgesic." He believes that "analgesic" should be the central driving force behind the development of JMP.
Of course, these three are not mutually exclusive. Adding sexy, powerful features can sometimes ease the pain. But "painkillers" are important because pain paralyzes us and demotivates us. Pain stops us in our tracks, preventing us from fully understanding what the data is telling us.
John Sall is co-founder and executive vice president of SAS Institute Inc., the world's leading business analytics software vendor. He is the creator and current head of the JMP business, the interactive, highly visible statistical exploration software for scientists and engineers.
Sall is also a fellow of the American Statistical Association and the American Association for the Advancement of Science (AAAS), one of the world's largest academic societies.
Additionally, his strong interest in international environmental conservation has led him to serve on the board of directors of the World Wildlife Fund (WWF), on the Natural History Advisory Committee of the Smithsonian Institution's National Museum of Natural History, and on the Board of Trustees of North Carolina State University.
*Dubbed in Japanese.
If you would like to listen to this presentation in the original audio, Here Click here.
Go to the session page under Discovery Summit Americas.
(Please note that you will be asked to log in to your SAS Profile.)
